GRI
GRI Bio Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.54
-0.38 ▼ -13.01%
🌙 3월 13일 7:46 PM ET (한국 3/14 08:46)
$2.53
-0.01 ▼ -0.39%
| Index | - | P/E | - | EPS (ttm) | -240.26 | Insider Own | 1.53% | Shs Outstand | 0.00B | Perf Week | -0.97% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | 47.79% | Insider Trans | - | Shs Float | 0.00B | Perf Month | 6.28% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -3.74 | Inst Own | 0.15% | Short Float | 9.52% | Perf Quarter | -92.5% |
| Income | -0.01B | P/S | - | EPS this Y | 87.38% | Inst Trans | 0.39% | Short Ratio | 0.34 | Perf Half Y | -95.57% |
| Sales | 0.00B | P/B | 0.21 | EPS next 5Y | 56.42% | ROA | -166% | Short Interest | 0.14M | Perf YTD | -63.24% |
| Book/sh | 12.07 | P/C | 0.45 | EPS past 3/5Y | 97.03% 83.24% | ROE | -238.17% | 52W High | -99.18% ($311.36) | Perf Year | -98.49% |
| Cash/sh | 5.7 | P/FCF | - | Sales past 3/5Y | - | ROIC | -198.51% | 52W Low | 20.95% ($2.10) | Perf 3Y | -100% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 95.78% | Gross Margin | - | Volatility(W/M) | 10.32% 9.14% | Perf 5Y | -100% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.4 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.25 | EPS Q/Q | 97.4% | Profit Margin | - | RSI (14) | 35.11 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.25 | Sales Q/Q | - | SMA20 | 0.88% ($2.52) | Beta | -1.45 | Target Price | $160 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/02/25 | SMA50 | -38% ($4.1) | Rel Volume | 0.16 | Prev Close | $2.92 |
| Employees | 4 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 54.72% - | SMA200 | -92.51% ($33.91) | Avg Volume(3M) | 0.40M | Price | $2.54 |
| IPO | 2021/2/10 | Option/Short | No/Yes | Trades | 415 | Volume | 62,356 | Change | -13.01% |
뉴스 로딩 중...